A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine. - Dart CR; Mukherjee N; Amato CM; Goulding A; MacBeth M; Van Gulick R; Couts KL; Lambert JR; Norris DA; Robinson WA; Shellman YG (Pharmaceuticals (Basel, Switzerland), 2021)